Pay in 4 interest-free payments of $5.93 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
While GLP-1RAs offer substantial benefits, their psychological impact requires further investigation to ensure long-term safety
Ania MJ, Lee MK, Juan PF, Qiwei W, Yu D, Sirel G, et al
While Foundayo is already approved by the Food and Drug Administration, the need to continue testing does not stop there
Fast Risers: AstraZeneca, Lilly, and Novo Nordisk The fastest-growing companies in the top 10 were AstraZeneca, with all of its key therapy areas seeing sales rise by double-digit percentages, and Eli Lilly, driven by its tirzepatide GIP/GLP-1 receptor agonist products for diabetes and obesity, Mounjaro and Zepbound
US$ 25.10
US$ 21.89
US$ 28.06
US$ 26.96
US$ 28.31
US$ 20.48
US$ 23.55
US$ 28.17
US$ 26.89
US$ 28.42
